Eleven Biotherapeutics Inc (NASDAQ:EBIO)

11.22
Delayed Data
As of 12:12pm ET
 +0.03 / +0.27%
Today’s Change
7.22
Today|||52-Week Range
14.12
-5.56%
Year-to-Date

Today’s Trading

Previous close11.19
Today’s open11.35
Day’s range10.89 - 11.61
Volume200,909
Average volume (3 months)88,974
Market cap$202.6M
Dividend yield--
Data as of 12:12pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)-66.90%
Earnings growth (this year)+18.23%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+68.14%
P/E ratioNM
Price/Sales77.56
Price/Book5.45

Competitors

 Today’s
change
Today’s
% change
EPRSEPIRUS Biopharmaceut...-0.77-8.88%
RPRXRepros Therapeutics ...-0.19-2.25%
ACRXAcelRx Pharmaceutica...-0.20-4.30%
INNLInnocoll AG+0.09+0.91%
Data as of 12:28pm ET, 04/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$2.2M
Annual profit (last year)-$34.2M
Net profit margin-1,522.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Chief Financial &
Business Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers